In this month’s From the Editor’s Desk, Dr. Schapira talks about the challenges of when it’s time for cancer survivors to say goodbye to their oncologists.
In this month’s From the Editor’s Desk, Dr. Schapira talks about the power that the word "cancer" has and how it can influence important decisions about treatment plans.
People with cancer should be careful to avoid handling or eating recalled food products. Here’s what to do if you may have a recalled food in your home.
Can immunotherapy be used to treat breast cancer? This expert Q&A explains.
In this month’s From the Editor’s Desk, Dr. Schapira reflects on this year’s Advance of the Year and what it says about cancer research more broadly.
In this podcast, Lineagotica Associate Editor Dr. Michael Williams describes lymphoma research advances presented at the American Society of Hematology Annual Meeting.
In her first From the Editor’s Desk of 2019, Dr. Schapira writes about setting goals and resolutions for the new year and how exercise helps people with cancer regain a much-needed sense of control and success in their lives.
Some recent FDA approvals have made many people aware of tumor-agnostic treatments. But what does that mean and how could it benefit someone with cancer? ASCO Chief Medical Officer Richard L. Schilsky gives insight into this new way of thinking about cancer treatment.
In this month’s From the Editor’s Desk, Dr. Schapira discusses the role of tracking and reporting side effects in high-quality care, including advances in patient-reported outcomes or PROs.